SPOTLIGHT: Prof to FTC: Vioxx deal violates antitrust


A University of Virginia Law School prof has complained about the big Vioxx settlement to the Federal Trade Commission, alleging that the deal violates antitrust law. Report

Suggested Articles

Compared with the FDA "boxed warning," the EMA version puts a smaller restriction on the higher dose but broadens the cautionary language.

Shionogi's newest antibiotic Fetroja has now earned the FDA's approval, but will a mortality-rate warning scuttle the drug's chances?

Novartis' Sandoz doubled down in Japan as Lupin retreated. Dr. Reddy's posted a loss tied to its Zantac recall. Aslan's varlitinib failed again.